1. Home
  2. CVE Database
  3. CVE-2022-48226
HIGH · 7.8

CVE-2022-48226

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain el...

Vulnerability Description

An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain elevated code execution. Permissions need to be modified to prevent manipulation.

CVSS Score

7.8

HIGH

CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
Attack Vector
LOCAL
Attack Complexity
LOW
Privileges Required
LOW
User Interaction
NONE
Scope
UNCHANGED
Confidentiality
HIGH
Integrity
HIGH
Availability
HIGH

Affected Products

VendorProductVersions
GbgplcAcuant Acufill Sdk< 10.22.02.03

Related Weaknesses (CWE)

CWE-269

References

FAQ

What is CVE-2022-48226?

CVE-2022-48226 is a vulnerability with a CVSS score of 7.8 (HIGH). An issue was discovered in Acuant AcuFill SDK before 10.22.02.03. During installation, an EXE gets executed out of C:\Windows\Temp. A standard user can create the path file ahead of time and obtain el...

How severe is CVE-2022-48226?

CVE-2022-48226 has been rated HIGH with a CVSS base score of 7.8/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2022-48226?

Check the references section above for vendor advisories and patch information. Affected products include: Gbgplc Acuant Acufill Sdk.